(PharmaNewsWire.Com, September 24, 2019 ) According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world use glucose meter, test strips and lancing device to measure the blood glucose level. There are many diabetes patients especially insulin dependent that has severe hypoglycemic and hyperglycemic index level. They use 3-4 or even more than that strips on the daily basis to monitor the blood glucose level. As monitoring blood glucose is an essential part of diabetes management. Moreover, SMBG device are convenient to use at any point of time before breakfast, before meal, after meal and before after exercise. According to Renub Research the Global Blood Glucose Device Market is expected to surpass US$ 20 Billion mark by the end of the year 2025.
The SMBG market is growing with rapid pace due to numerous key factors like rising global diabetes population (type 1 diabetes and type 2 diabetes), increasing insulin dependent diabetes population, increasing obese population, rise in ageing population, rising awareness regarding diabetes and technological advancement of SMBG device that makes convenience for patient to easily measure blood glucose level. According to Renub Research Analysis, rising penetration of SMBG user among developed and developing countries will further boost the global blood glucose device market in forecast year.
China has the Highest Diabetes Population in the World
Diabetes prevalence in China has been growing with rapid pace and it become one of the largest diabetes country in the world. Nearly 114 million people affected with diabetes in China but the prevalence of SMBG user in China was quite low as compared to developed countries. Changing lifestyle and food habits is the key reason to increase diabetes population in China.
In this report, we have taken diabetes population of 17 countries; United States, United Kingdom, India, Netherlands, Germany, Australia, Spain, Russia, Brazil, Kuwait, Switzerland, China, Italy, Norway, Sweden, South Africa and Saudi Arabia etc. here we have fragmented diabetes population of each country into two parts; Type 1 Diabetes and Type 2 Diabetes.
Self-Monitoring Blood Glucose Devices Insight
In this report, we have done comprehensive analysis of SMBG user like; their frequency of utilizing test-strips, its market and number of people that uses device. SMBG is mainly used by type 1 diabetes population and insulin user of type 2 diabetes to monitor their blood glucose. In addition, the people those are facing hypoglycemia and hyperglycemia are also frequent user of SMBG device. In this report, we have divided SMBG user into two parts; type 1 diabetes user and type 2 diabetes users. Here SMBG report constitutes three components; Test Strips, Lancet Device and Glucose Meter.
Blood Glucose Device Market - 17 Countries Covered in this Report:
America
1. United States 2. Brazil
Europe
3. United Kingdom 4. Germany 5. Spain 6. Italy 7. Netherlands 8. Norway 9. Sweden 10. Switzerland 11. Russia
Asia & Pacific
12. India 13. China 14. Australia
Middle East & Africa
15. Kuwait 16. Saudi Arabia 17. South Africa
Blood Glucose Device Market, Users Global Forecast, SMBG Components (Test Strips, Lancet, Meter) of 17 Countries (USA, Europe, Asia & Pacific, Middle East & Africa) & Companies (Roche, LifeScan Inc. HealthCare, Abbott) analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 5th publication on Blood Glucose Device Market by Renub Research.
This report studies the separate comprehensive analytics for the 17 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2019 through 2025. A six year historic analysis is also provided for these markets.
Research & Methodology
At the preliminary level, we have taken diabetes population of the country in the form of diabetes type1 population + diabetes type 2 population.
For Type 1 Diabetes: In this report, we have calculated the market of Test Strips, Lancet and Glucose Meter separately. In Type 1 diabetes almost everyone uses test strips to measure blood glucose. We have identified how many times type 1 diabetes patients uses test strips per day. What is the average cost of test strips in each country? Then we have multiplied it with the type 1 diabetes user to annual average cost of test strips (region wise).
For Type 2 Diabetes: We have studied many reports like cohort studies from many publication and credible source like diabetes.org, JDRF and National Center for Biotechnology Information and pub-med etc to identify number of insulin users in type 2 diabetes. In type 2 diabetes we have considered the following person who uses insulin:
1) People use Insulin only 2) People use Insulin + Pill 3) People use Pill only 4) People use nothing except diet control
So we have taken two sections; 1) Insulin only and 2) insulin + pill and again identified how many test strips used by insulin only patients and insulin + pill patients to calculate the market
How the Market is defined in the Report
Test Strips Market: Type 1 Test Strips Market + Type 2 Insulin only Test Strips Market + Type 2 Insulin + Pill Test Strips Market Lancet Market: Type 1 Lancet Market + Type 2 Insulin only Lancet Market + Type 2 Insulin + Pill Lancet Market Glucose Meter Market: Type 1 Glucose Meter Market + Type 2 Glucose Meter Market Blood Glucose Device (SMBG) Market: Test Strips Market of the Country + Lancet Market of the Country + Glucose Meter Market of the Country
Forecast Model
We have taken multiple factors for the forecast of Blood Glucose Device (SMBG) User and Market
Overall Diabetes Population Type 1 Diabetes Population Type 2 Diabetes Population Level of Government reimbursement policies Cost of SMBG components; test strips, lancet and glucose meter Per Capita GDP income Private Insurance Companies Penetration Technological Advancement
Test Strip, Lancet, Glucose Meter Market, and Diabetes Population of 17 Countries covered as follows
Diabetes Population Scenario and Forecast in all 17 countries Type 1 and Type 2 Diabetes Scenario and Forecast in all 17 countries Blood Glucose (SMBG) Devices Users and Forecast in all 17 countries Blood Glucose Devices (SMBG) Market and Forecast in all 17 countries Test Strips Market and Forecast in all 17 countries Lancet Market and Forecast in all 17 countries Meter Market and Forecast in all 17 countries
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
